PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study supports using virtual environment to teach mind/body techniques

Participants express satisfaction with learning stress-reducing techniques via Second Life online environment

2012-04-02
(Press-News.org) A small study from Massachusetts General Hospital (MGH) researchers found that online virtual communities may be an effective way to train patients in meditation and other mind/body techniques. The ability to learn and practice approaches that elicit the relaxation response – a state of deep rest that has been shown to alleviate stress-related symptoms – in a virtual environment could help surmount several barriers that can restrict participation.

"Our finding that a medical intervention – in this case teaching a mind/body approach that includes the relaxation response – can be delivered via a virtual environment is important because these environments are are richer and more rewarding than simply using interactive web sites," says Daniel Hoch, MD, PhD, of the Benson-Henry Institute for Mind Body Medicine at MGH (http://www.massgeneral.org/bhi/), corresponding author of the report appearing in the open-access journal PLoS One.

Hoch explains that, while practices that elicit the relaxation response have been shown to benefit individuals with a wide variety of health problems, the traditional way of teaching these practices – face-to-face meetings over several weeks – can present significant difficulties for patients, particularly those with limited mobility. In addition, individuals who are uncomfortable with group programs may prefer the anonymity of a virtual educational setting. While Internet-based programs have been used for mental health screening and support programs, Hoch and his colleagues were not aware of any prior efforts to systematically study a virtual mind-body intervention.

To test whether delivering such a program through a virtual environment was feasible, the research team chose Second Life, a three-dimensional "virtual world" in which users interact by means of online avatars that can communicate basic body language and emotional states. Several patient support groups, including groups for individuals with neurologic disorders, have established Second Life communities to share information and experiences. To adapt traditional face-to-face teaching methods to a virtual environment, Hoch brought experienced Benson-Henry clinicians together with experts in applications of Second Life to design the program.

Because learning to use Second Life can be challenging, the study only enrolled healthy individuals who had experience in the virtual environment. Participants enrolled in groups of up to 10 individuals and participated in twice-weekly virtual meetings led by an experienced Benson-Henry clinician. The clinician taught different methods of eliciting the relaxation response, guided participants through their practice, answered questions and discussed the participants' experiences. Group members were asked to elicit the relaxation response for at least 20 minutes each day – either in front of the computer with their avatar in the Second Life virtual teaching area or in another quiet setting – and received audio and video files and other supporting information. Before and after the eight weeks of online sessions, participants completed standard questionnaires assessing stress and other psychological symptoms.

The full study was completed by 24 individuals in three groups, all receiving the same training program. Although the small size of the study made it difficult to arrive at statistically significant results, overall participants showed reductions in depression- and anxiety-related symptoms. They also reported being very satisfied with the virtual environment, and several commented that they could not have taken part without the online option. Although most admitted that a face-to-face teaching environment would be even better, they also noted that the time required to travel to in-person meetings would have presented difficulties.

"Several participants have let us know, several months later, that they continue to use techniques they learned in these sessions to reduce stress in their everyday lives," Hoch says. "The Second Life technology is changing rapidly and its creators have scaled back their interest in educational and clinical activities, so we're now hoping to explore the ability to have secure patient interactions in web-browser-based environments. One of the applications that I feel holds a great deal of promise is using this approach to help patients with post-traumatic stress, so I'm hopeful we'll have the opportunity to try that in the near future."

"Social networks and online communities represent an important element of support, information and motivation for many patients," adds Joseph Kvedar, MD, director of the Center for Connected Health (http://www.connected-health.org/), Partners HealthCare, and a co-author of the PLoS One report. "Connected health strategies are creating new opportunities to deliver quality care, for patients and providers to communicate effectively and help motivate and educate patients to stay on track with their treatment plan."

INFORMATION:

Hoch is an assistant professor of Neurology and Kvedar an associate professor of Dermatology at Harvard Medical School. Additional co-authors of the PLoS One article are Mariola Milik, Margaret Baim, MS, NP, Gregory Fricchione, MD, and Herbert Benson, MD, Benson-Henry Institute for Mind Body Medicine; Kamal Jethwani, MB, BS, Center for Connected Health and MGH Dermatology; Alice Watson, MB, ChB, MGH Dermatology; Heather Bello, Harvard School of Public Health; Deborah Linton, Health 2.0, San Francisco; and Marco Sennely, OneVision Solutions, Austin, Texas.

Massachusetts General Hospital (www.massgeneral.org), founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $750 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.

END



ELSE PRESS RELEASES FROM THIS DATE:

NASA sees Typhoon Pakhar headed for Vietnam landfall

NASA sees Typhoon Pakhar headed for Vietnam landfall
2012-04-02
The first typhoon of the northern hemisphere 2012 typhoon season is headed for landfall in Vietnam. NASA's Aqua and TRMM satellites have been providing forecasters with valuable data on Typhoon Pakhar, that includes rainfall rates, cloud extent and temperature. The Tropical Rainfall Measuring Mission (TRMM) satellite flew almost directly over Pakhar when it was a newly formed tropical storm in the South China Sea on March 29, 2012 at 1122 UTC/4:22 p.m. Asia local time (or 7:22 a.m. EDT). The intensifying storm had wind speeds of about 45 knots (~52 mph/~83 kph) and was ...

Images capture split personality of dense suspensions

Images capture split personality of dense suspensions
2012-04-02
Stir lots of small particles into water, and the resulting thick mixture appears highly viscous. When this dense suspension slips through a nozzle and forms a droplet, however, its behavior momentarily reveals a decidedly non-viscous side. University of Chicago physicists recorded this surprising behavior in laboratory experiments using high-speed photography that can capture action taking place in one hundred-thousandths of a second or less. UChicago graduate student Marc Miskin and Heinrich Jaeger, the William J. Friedman and Alicia Townsend Friedman Professor in Physics, ...

Tokai Pharmaceuticals' galeterone well-tolerated in patients with advanced prostate cancer

2012-04-02
CAMBRIDGE, Mass. and CHICAGO, Ill. -- Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that its lead candidate galeterone (TOK-001) was well-tolerated with minimal side effects and demonstrated efficacy in patients with castration-resistant prostate cancer (CRPC) in a Phase 1 study. The data will be presented in an oral presentation titled, "ARMOR1: Safety of galeterone (TOK-001) in a Phase 1 clinical trial in chemotherapy naïve patients with castration-resistant prostate cancer (CRPC)," abstract ...

Early clinical data show galeterone safe, effective against prostate cancer

2012-04-02
CHICAGO — Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug, according to phase I data presented at the AACR Annual Meeting 2012, held here March 31 - April 4. Castration-resistant prostate cancer (CRPC) is an advanced form of prostate cancer that occurs when the disease progresses after treatment with androgen deprivation therapy. Galeterone works against CRPC by blocking the androgen receptor, reducing levels of the ligand ...

Metformin appeared to slow prostate cancer growth

2012-04-02
CHICAGO — The use of metformin in men with prostate cancer before prostatectomy helped to reduce certain metabolic parameters and slow the growth rate of the cancer, according to the results of a phase II study. Anthony M. Joshua, M.B.B.S., Ph.D., staff medical oncologist at the Princess Margaret Hospital, University Health Network in Toronto, Ontario, Canada, presented the data at the AACR Annual Meeting 2012, held here March 31 - April 4. Metformin is the most commonly prescribed medication for diabetes. Prior laboratory research has suggested that metformin may ...

Biomarker identified in relation to drug response in refractory urothelial cancer

2012-04-02
CHICAGO — The antiangiogenic drug pazopanib has demonstrated clinically meaningful activity in patients with refractory urothelial cancer, according to results presented at the AACR Annual Meeting 2012, held here March 31 - April 4. The results also revealed that increases in interleukin-8 levels early after treatment with pazopanib may predict a lack of tumor response to the therapy. "Historically, prognosis of patients with relapsed or refractory urothelial cancer is quite dismal," said Andrea Necchi, M.D., faculty member in the department of medicine at Fondazione ...

Towards TB elimination: ECDC and ERS introduce new guidelines on tuberculosis care in Europe

2012-04-02
Today, the European Respiratory Society (ERS) and the European Centre for Disease Prevention and Control (ECDC) publish their jointly developed European Union Standards for Tuberculosis Care (ESTC). The 21 patient-centred standards aim to guide clinicians and public health workers to ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) in Europe – with nearly 74,000 reported TB cases in the EU/EEA in 2010 clearly showing that TB remains a public health challenge across the region. The new EU-specific guidelines were developed by a panel of 30 experts ...

Oxygen in tumors predicts prostate cancer recurrence

2012-04-02
TORONTO -- Low oxygen levels in tumors can be used to predict cancer recurrence in men with intermediate-risk prostate cancer even before they receive radiation therapy. The clinical research, led by radiation oncologists at the Princess Margaret Hospital (PMH) Cancer Program, University Health Network (UHN) is published online today in Clinical Cancer Research, a journal of the American Association for Cancer Research (doi: 10.1158/1078-0432.CCR-11-2711). "We've not only shown that men do worse if they have low oxygen levels (hypoxia) in their prostate cancer, but ...

2 targeted therapies act against Ewing's sarcoma tumors

2012-04-02
CHICAGO - A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012. Five of 17 Ewing's sarcoma patients responded to the combination, with two achieving complete responses, one for 27 weeks. The researchers noted that the ability to manage patients' treatment-related side effects is vital to maintaining the therapy and slowing disease progression. ...

Commonly used diabetes drug may help to prevent primary liver cancer

2012-04-02
Baltimore, MD – March 31, 2012. Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research. Primary liver cancer, or hepatocellular carcinoma, is an often-deadly form of cancer that is on the rise worldwide and is the fastest-growing cause of cancer-related deaths among American men. Patients with Type II diabetes have a two- to three-fold increased relative risk of developing primary ...

LAST 30 PRESS RELEASES:

We should talk more at school: Researchers call for more conversation-rich learning as AI spreads

LHAASO uncovers mystery of cosmic ray "knee" formation

The simulated Milky Way: 100 billion stars using 7 million CPU cores

Brain waves’ analog organization of cortex enables cognition and consciousness, MIT professor proposes at SfN

Low-glutamate diet linked to brain changes and migraine relief in veterans with Gulf War Illness

AMP 2025 press materials available

New genetic test targets elusive cause of rare movement disorder

A fast and high-precision satellite-ground synchronization technology in satellite beam hopping communication

What can polymers teach us about curing Alzheimer's disease?

Lead-free alternative discovered for essential electronics component

BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders

Skin cancer cluster found in 15 Pennsylvania counties with or near farmland

For platforms using gig workers, bonuses can be a double-edged sword

Chang'e-6 samples reveal first evidence of impact-formed hematite and maghemite on the Moon

New study reveals key role of inflammasome in male-biased periodontitis

MD Anderson publicly launches $2.5 billion philanthropic campaign, Only Possible Here, The Campaign to End Cancer

Donors enable record pool of TPDA Awards to Neuroscience 2025

Society for Neuroscience announces Gold Sponsors of Neuroscience 2025

The world’s oldest RNA extracted from woolly mammoth

Research alert: When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show

Reading a quantum clock costs more energy than running it, study finds

Early MMR vaccine adoption during the 2025 Texas measles outbreak

Traces of bacteria inside brain tumors may affect tumor behavior

Hypertension affects the brain much earlier than expected

Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio

Drift logs destroying intertidal ecosystems

New test could speed detection of three serious regional fungal infections

New research on AI as a diagnostic tool to be featured at AMP 2025

New test could allow for more accurate Lyme disease diagnosis

New genetic tool reveals chromosome changes linked to pregnancy loss

[Press-News.org] Study supports using virtual environment to teach mind/body techniques
Participants express satisfaction with learning stress-reducing techniques via Second Life online environment